Review



invivo2  (Baker Company)


Bioz Verified Symbol Baker Company is a verified supplier
Bioz Manufacturer Symbol Baker Company manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 97
      Buy from Supplier

    Structured Review

    Baker Company invivo2
    Invivo2, supplied by Baker Company, used in various techniques. Bioz Stars score: 97/100, based on 1701 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/invivo2/InvivO2/custom%40invivo-001%4042737749
    Average 97 stars, based on 1701 article reviews
    invivo2 - by Bioz Stars, 2026-09
    97/100 stars

    Images

    Related Articles

    Incubation:

    Article Title: NLRP3 Regulation in Neonatal Hypoxic-Ischemic Encephalopathy-Focus on Microglial Activation.
    Article Snippet: 27177853 rity threshold of 90% was applied. The cells were subjected to oxygen–glucose deprivation (OGD) the following day. OGD was performed in a hypoxic chamber (0.1% O2, 5% CO2, 37 ◦C; InvivO2 400, Baker Ruskinn, Sanford, ME, USA). Cells were washed and incubated in glucose-free DMEM for 6 h (pilot experiments; cell death < 30%). The medium was then replaced with culture medium and the cells wer

    Control:

    Article Title: NLRP3 Regulation in Neonatal Hypoxic-Ischemic Encephalopathy-Focus on Microglial Activation.
    Article Snippet: 27177853 rity threshold of 90% was applied. The cells were subjected to oxygen–glucose deprivation (OGD) the following day. OGD was performed in a hypoxic chamber (0.1% O2, 5% CO2, 37 ◦C; InvivO2 400, Baker Ruskinn, Sanford, ME, USA). Cells were washed and incubated in glucose-free DMEM for 6 h (pilot experiments; cell death < 30%). The medium was then replaced with culture medium and the cells wer

    Clone Assay:

    Article Title: NLRP3 Regulation in Neonatal Hypoxic-Ischemic Encephalopathy-Focus on Microglial Activation.
    Article Snippet: 27177853 rity threshold of 90% was applied. The cells were subjected to oxygen–glucose deprivation (OGD) the following day. OGD was performed in a hypoxic chamber (0.1% O2, 5% CO2, 37 ◦C; InvivO2 400, Baker Ruskinn, Sanford, ME, USA). Cells were washed and incubated in glucose-free DMEM for 6 h (pilot experiments; cell death < 30%). The medium was then replaced with culture medium and the cells wer

    Microscopy:

    Article Title: NLRP3 Regulation in Neonatal Hypoxic-Ischemic Encephalopathy-Focus on Microglial Activation.
    Article Snippet: 27177853 rity threshold of 90% was applied. The cells were subjected to oxygen–glucose deprivation (OGD) the following day. OGD was performed in a hypoxic chamber (0.1% O2, 5% CO2, 37 ◦C; InvivO2 400, Baker Ruskinn, Sanford, ME, USA). Cells were washed and incubated in glucose-free DMEM for 6 h (pilot experiments; cell death < 30%). The medium was then replaced with culture medium and the cells wer

    Sequencing:

    Article Title: NLRP3 Regulation in Neonatal Hypoxic-Ischemic Encephalopathy-Focus on Microglial Activation.
    Article Snippet: 27177853 rity threshold of 90% was applied. The cells were subjected to oxygen–glucose deprivation (OGD) the following day. OGD was performed in a hypoxic chamber (0.1% O2, 5% CO2, 37 ◦C; InvivO2 400, Baker Ruskinn, Sanford, ME, USA). Cells were washed and incubated in glucose-free DMEM for 6 h (pilot experiments; cell death < 30%). The medium was then replaced with culture medium and the cells wer

    Transfection:

    Article Title: NLRP3 Regulation in Neonatal Hypoxic-Ischemic Encephalopathy-Focus on Microglial Activation.
    Article Snippet: 27177853 rity threshold of 90% was applied. The cells were subjected to oxygen–glucose deprivation (OGD) the following day. OGD was performed in a hypoxic chamber (0.1% O2, 5% CO2, 37 ◦C; InvivO2 400, Baker Ruskinn, Sanford, ME, USA). Cells were washed and incubated in glucose-free DMEM for 6 h (pilot experiments; cell death < 30%). The medium was then replaced with culture medium and the cells wer

    Confocal Microscopy:

    Article Title: NLRP3 Regulation in Neonatal Hypoxic-Ischemic Encephalopathy-Focus on Microglial Activation.
    Article Snippet: 27177853 rity threshold of 90% was applied. The cells were subjected to oxygen–glucose deprivation (OGD) the following day. OGD was performed in a hypoxic chamber (0.1% O2, 5% CO2, 37 ◦C; InvivO2 400, Baker Ruskinn, Sanford, ME, USA). Cells were washed and incubated in glucose-free DMEM for 6 h (pilot experiments; cell death < 30%). The medium was then replaced with culture medium and the cells wer

    Immunofluorescence:

    Article Title: NLRP3 Regulation in Neonatal Hypoxic-Ischemic Encephalopathy-Focus on Microglial Activation.
    Article Snippet: 27177853 rity threshold of 90% was applied. The cells were subjected to oxygen–glucose deprivation (OGD) the following day. OGD was performed in a hypoxic chamber (0.1% O2, 5% CO2, 37 ◦C; InvivO2 400, Baker Ruskinn, Sanford, ME, USA). Cells were washed and incubated in glucose-free DMEM for 6 h (pilot experiments; cell death < 30%). The medium was then replaced with culture medium and the cells wer

    Polymerase Chain Reaction:

    Article Title: NLRP3 Regulation in Neonatal Hypoxic-Ischemic Encephalopathy-Focus on Microglial Activation.
    Article Snippet: 27177853 rity threshold of 90% was applied. The cells were subjected to oxygen–glucose deprivation (OGD) the following day. OGD was performed in a hypoxic chamber (0.1% O2, 5% CO2, 37 ◦C; InvivO2 400, Baker Ruskinn, Sanford, ME, USA). Cells were washed and incubated in glucose-free DMEM for 6 h (pilot experiments; cell death < 30%). The medium was then replaced with culture medium and the cells wer

    Real-time Polymerase Chain Reaction:

    Article Title: NLRP3 Regulation in Neonatal Hypoxic-Ischemic Encephalopathy-Focus on Microglial Activation.
    Article Snippet: 27177853 rity threshold of 90% was applied. The cells were subjected to oxygen–glucose deprivation (OGD) the following day. OGD was performed in a hypoxic chamber (0.1% O2, 5% CO2, 37 ◦C; InvivO2 400, Baker Ruskinn, Sanford, ME, USA). Cells were washed and incubated in glucose-free DMEM for 6 h (pilot experiments; cell death < 30%). The medium was then replaced with culture medium and the cells wer

    Plasmid Preparation:

    Article Title: NLRP3 Regulation in Neonatal Hypoxic-Ischemic Encephalopathy-Focus on Microglial Activation.
    Article Snippet: 27177853 rity threshold of 90% was applied. The cells were subjected to oxygen–glucose deprivation (OGD) the following day. OGD was performed in a hypoxic chamber (0.1% O2, 5% CO2, 37 ◦C; InvivO2 400, Baker Ruskinn, Sanford, ME, USA). Cells were washed and incubated in glucose-free DMEM for 6 h (pilot experiments; cell death < 30%). The medium was then replaced with culture medium and the cells wer

    Cell Culture:

    Article Title: NLRP3 Regulation in Neonatal Hypoxic-Ischemic Encephalopathy-Focus on Microglial Activation.
    Article Snippet: 27177853 rity threshold of 90% was applied. The cells were subjected to oxygen–glucose deprivation (OGD) the following day. OGD was performed in a hypoxic chamber (0.1% O2, 5% CO2, 37 ◦C; InvivO2 400, Baker Ruskinn, Sanford, ME, USA). Cells were washed and incubated in glucose-free DMEM for 6 h (pilot experiments; cell death < 30%). The medium was then replaced with culture medium and the cells wer

    Concentration Assay:

    Article Title: NLRP3 Regulation in Neonatal Hypoxic-Ischemic Encephalopathy-Focus on Microglial Activation.
    Article Snippet: 27177853 rity threshold of 90% was applied. The cells were subjected to oxygen–glucose deprivation (OGD) the following day. OGD was performed in a hypoxic chamber (0.1% O2, 5% CO2, 37 ◦C; InvivO2 400, Baker Ruskinn, Sanford, ME, USA). Cells were washed and incubated in glucose-free DMEM for 6 h (pilot experiments; cell death < 30%). The medium was then replaced with culture medium and the cells wer

    Generated:

    Article Title: NLRP3 Regulation in Neonatal Hypoxic-Ischemic Encephalopathy-Focus on Microglial Activation.
    Article Snippet: 27177853 rity threshold of 90% was applied. The cells were subjected to oxygen–glucose deprivation (OGD) the following day. OGD was performed in a hypoxic chamber (0.1% O2, 5% CO2, 37 ◦C; InvivO2 400, Baker Ruskinn, Sanford, ME, USA). Cells were washed and incubated in glucose-free DMEM for 6 h (pilot experiments; cell death < 30%). The medium was then replaced with culture medium and the cells wer

    Transformation Assay:

    Article Title: NLRP3 Regulation in Neonatal Hypoxic-Ischemic Encephalopathy-Focus on Microglial Activation.
    Article Snippet: 27177853 rity threshold of 90% was applied. The cells were subjected to oxygen–glucose deprivation (OGD) the following day. OGD was performed in a hypoxic chamber (0.1% O2, 5% CO2, 37 ◦C; InvivO2 400, Baker Ruskinn, Sanford, ME, USA). Cells were washed and incubated in glucose-free DMEM for 6 h (pilot experiments; cell death < 30%). The medium was then replaced with culture medium and the cells wer

    Knockdown:

    Article Title: NLRP3 Regulation in Neonatal Hypoxic-Ischemic Encephalopathy-Focus on Microglial Activation.
    Article Snippet: 27177853 rity threshold of 90% was applied. The cells were subjected to oxygen–glucose deprivation (OGD) the following day. OGD was performed in a hypoxic chamber (0.1% O2, 5% CO2, 37 ◦C; InvivO2 400, Baker Ruskinn, Sanford, ME, USA). Cells were washed and incubated in glucose-free DMEM for 6 h (pilot experiments; cell death < 30%). The medium was then replaced with culture medium and the cells wer



    Similar Products

    invivo2  (Baker Company)
    97
    Baker Company invivo2
    Invivo2, supplied by Baker Company, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/invivo2/InvivO2/custom%40invivo-001%4042737749
    Average 97 stars, based on 1 article reviews
    invivo2 - by Bioz Stars, 2026-09
    97/100 stars
    		  Buy from Supplier

    Image Search Results